Dr. Reddy's Laboratories reports 33% rise in Q2 consolidated net profit

27 Oct 2023 Evaluate

Dr. Reddy's Laboratories has reported results for second quarter ended September 30, 2023 (Q2FY24). 

The company has reported 6.84% rise in its net profit at Rs 1192.60 crore for Q2FY24 as compared to Rs 1116.30 crore for the same quarter in the previous year. Total income of the company increased marginally by 1.27% at Rs 5061.80 crore for Q2FY24 as compared Rs 4998.30 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 33.03% rise in its net profit at Rs 1482.20 crore for the quarter under review as compared to Rs 1114.20 crore for the same quarter in the previous year. Total income of the company increased by 13.26% at Rs 7217.60 crore for Q2FY24 as compared Rs 6372.60 crore for the corresponding quarter previous year.

Dr. Reddys Lab Share Price

1213.90 19.35 (1.62%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.